Gene · 1871
Papers3,808
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,808
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pharmacogenomics of steroid-induced ocular hypertension: relationship to high-tension glaucomas and new pathophysiologic insight. | medRxiv | 2025 | 40832404 | PubTator, text mining | PubMed |
| Global research landscape of retinoblastoma biomarkers: a multidisciplinary bibliometric analysis based on multiple databases (2005-2025). | J Cancer Res Clin Oncol | 2025 | 40817296 | PubTator, text mining | PubMed |
| Elucidating the Role of MicroRNA 1827 as Diagnostic Biomarker in Prostate Cancer Progression. | Appl Biochem Biotechnol | 2025 | 40768178 | PubTator, text mining | PubMed |
| Effect of TP53 mutation, expression and polymorphism on the survival, immune infiltration and ferroptosis in patients with prostate cancer. | Oncol Lett | 2025 | 40740989 | PubTator, text mining | PubMed |
| Oncogene-Induced Senescence Transcriptomes Signify Premalignant Colorectal Adenomas. | Curr Issues Mol Biol | 2025 | 40699620 | PubTator, text mining | PubMed |
| Exploring novel genomic biomarkers for response and survival after neoadjuvant chemotherapy and radical cystectomy of muscle-invasive bladder cancer. | ESMO Open | 2025 | 40664147 | PubTator, text mining | PubMed |
| Regulation of ferroptosis by transcription factor E2F1. | Biochimie | 2025 | 40578750 | PubTator, text mining | PubMed |
| ELF1-mediated transactivation of METTL3/YTHDF2 promotes nucleus pulposus cell senescence via m6A-dependent destabilization of E2F3 mRNA in intervertebral disc degeneration. | Cell Death Discov | 2025 | 40467575 | PubTator, text mining | PubMed |
| The cell-permeable iron chelator M606 inhibits MYCN-driven neuroblastoma via an E2F3-mediated response. | Proc Natl Acad Sci U S A | 2025 | 40455982 | PubTator, text mining | PubMed |
| Dengue virus modulates critical cell cycle regulatory proteins in human megakaryocyte cells. | Sci Rep | 2025 | 40447783 | PubTator, text mining | PubMed |
| SOX4 as a Key Oncogene Driving Tumor Invasion in Retinoblastoma. | Invest Ophthalmol Vis Sci | 2025 | 40402518 | PubTator, text mining | PubMed |
| TACC3 enhances glycolysis in bladder cancer cells through inducing acetylation of c-Myc. | Cell Death Dis | 2025 | 40246827 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing of the holothurian regenerating intestine reveals the pluripotency of the coelomic epithelium. | Elife | 2025 | 40111904 | PubTator, text mining | PubMed |
| Significance of LRFN4 in prognosis and tumor microenvironment of lung adenocarcinoma. | Front Pharmacol | 2025 | 40070576 | PubTator, text mining | PubMed |
| [The expression of YTHDF2 in cervical lesions and its relationship with prognosis based on bioinformatics]. | Zhonghua Liu Xing Bing Xue Za Zhi | 2025 | 39965835 | PubTator, text mining | PubMed |
| Effect of microRNA-141-3p, E2F3, CDK3, and KAT2B overexpression on histologic tumor grade and metastasis status in untreated breast cancer tissues. | Bioimpacts | 2025 | 39963567 | PubTator, text mining | PubMed |
| Identification of differentially expressed MiRNA clusters in cervical cancer. | Discov Oncol | 2025 | 39946028 | PubTator, text mining | PubMed |
| Exploring the mechanism and drug candidates of alveolar echinococcosis affecting liver fibrosis through analysis of existing microarray data. | Acta Trop | 2025 | 39863141 | PubTator, text mining | PubMed |
| Deciphering the prognostic landscape of triple-negative breast cancer: A focus on immune-related hub genes and therapeutic implications. | Biotechnol Appl Biochem | 2025 | 39587411 | PubTator, text mining | PubMed |
| [Retracted] MicroRNA‑34a expression affects breast cancer invasion in vitro and patient survival via downregulation of E2F1 and E2F3 expression. | Oncol Rep | 2025 | 39540400 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1871/papers?page=4